Management of Cesarean Section Uterine Scar Ectopic Pregnancy Type 2 Using Methotrexate: Insights from a Case Report

Taylor Pigg; Susan Fields; Amalia Brawley; R. Paul Roddenberry; Padmashree C. Woodham

doi:10.12659/AJCR.948357

24 September 2025 : Case report USA

Management of Cesarean Section Uterine Scar Ectopic Pregnancy Type 2 Using Methotrexate: Insights from a Case Report

Unusual or unexpected effect of treatment

Taylor Pigg^{BCDEF 1*}, Susan Fields^{BCDEF 1}, Amalia Brawley^{BCDEF 1,2,3}, R. Paul Roddenberry^{E 4}, Padmashree C. Woodham

^{BCDEF 1,2,3}

DOI: 10.12659/AJCR.948357

Am J Case Rep 2025; 26:e948357

Authors information Article notes Copyright and License information

Introduction Case Report Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 2 beta-human chorionic gonadotropin (β-HCG) vs time: quantitative serum β-hCG in uMI/mL before and after intra-gestational methotrexate, reflective of values in Table 1.

Back to the Article

Management of Cesarean Section Uterine Scar Ectopic Pregnancy Type 2 Using Methotrexate: Insights from a Case Report

Your Privacy